US and UK guidelines for glucocorticoid-induced osteoporosis: similarities and differences.

被引：30

作者：

Compston J. ^{[1
]}

机构：

[1] Department of Medicine, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, Box 157, CB2 2QQ, Cambridge

来源：

Current Rheumatology Reports | 2004年 / 6卷 / 1期

关键词：

Bone Mineral Density; Bone Densitometry; Glucocorticoid Therapy; Nandrolone Decanoate; National Osteoporosis Society;

D O I：

10.1007/s11926-004-0085-1

中图分类号：

学科分类号：

摘要：

Osteoporosis is a common and serious complication of glucocorticoid therapy. Recent advances in the epidemiology, pathophysiology, and management of glucocorticoid-induced osteoporosis have stimulated the development of guidelines for the prevention and treatment of this condition. In this report, the updated recommendations of the American College of Rheumatology and guidelines recently produced by the Bone and Tooth Society, National Osteoporosis Society, and Royal College of Physicians in the UK are discussed with respect to their similarities and differences.

引用

页码：66 / 69

页数：3

共 70 条

[1]

Walsh LJ(1996)Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study BMJ 313 344-346

[2]

Wong CA(2000)Use of oral corticosteroids in the United Kingdom QJM 93 105-111

[3]

Pringle M(2000)Use of oral corticosteroids and risk of fractures J Bone Miner Res 15 993-1000

[4]

Tattersfield AE(2001)Use of inhaled corticosteroids and risk of fractures J Bone Miner Res 16 581-588

[5]

van Staa TP(2002)A meta-analysis of the epidemiology of corticosteroid-induced osteoporosis Osteoporos Int 13 777-787

[6]

Leufkens HGM(1997)Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis N Engl J Med 337 382-387

[7]

Abenhaim L(1998)Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis N Engl J Med 339 292-299

[8]

van Staa TP(1999)Risedronate therapy prevents corticosteroid-induced bone loss Arthritis Rheum 42 2309-2318

[9]

Leufkens HGM(2000)Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial J Bone Miner Res 15 1006-1013

[10]

Abenhaim L(2001)Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis Arthritis Rheum 44 1496-1503

← 1 2 3 4 5 6 7 →